Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

被引:35
作者
Penel, N
Fournier, C
Clisant, S
N'Guyen, M
机构
[1] Ctr Oscar Lambret, Dept Cancerol Gen, F-59020 Lille, France
[2] Ctr Oscar Lambret, Biostat Unit, F-59020 Lille, France
[3] Ctr Oscar Lambret, Unite Rech Clin, F-59020 Lille, France
[4] Ctr Oscar Lambret, Biol Lab, F-59020 Lille, France
关键词
fever; cancer; procalcitonin; diagnosis; infection; C-reactive protein; paraneoplastic fever;
D O I
10.1007/s00520-004-0602-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aims of our retrospective study were to study first the causes of 245 febrile episodes in cancer patients and then the value of procalcitonin (PCT) and C-reactive protein (CRP) in differentiating infections from paraneoplastic fever. Method. The causes of fever were studied in 245 consecutive cases observed between January and December 2002, and PCT and CRP diagnostic value in 155 cases (114 infections and 41 paraneoplastic fever). Results. The two main causes of fever were infection (121 cases) and paraneoplastic fever (43 cases); 77 infections were microbiologically documented. Cocci gram positive caused 41 out of 77 documented infections. Paraneoplastic fever was more frequent in metastatic disease (p=6.10(-6)). CRP and PCT serum levels at admission did not differ significantly in the infection group and paraneoplastic fever group (respectively p=0.39 and p=0.14 with Mann-Whitney test). The PCT and CRP levels had poor prognostic value in infection (respectively 0.04 and 0.0003 with Mann-Whitney test). Conclusion. Causes of fever are very numerous in cancer patients (more than 75 different causes in this study). Bacterial infection is the most frequent cause. PCT and CRP failed to discriminate infection, but both had pejorative prognostic value in infected patients.
引用
收藏
页码:593 / 598
页数:6
相关论文
共 35 条
[1]   Procalcitonin in patients with and without immunosuppression and sepsis [J].
AlNawas, B ;
Shah, PM .
INFECTION, 1996, 24 (06) :434-436
[2]  
[Anonymous], CLIN LAB
[3]   Change in serum procalcitonin (PCT) predicts the clinical outcome of children admitted with febrile neutropenia [J].
Barnes, C ;
Ignjatovic, V ;
Newall, F ;
Carlin, J ;
Ng, F ;
Hamilton, S ;
Ashley, D ;
Waters, K ;
Monagle, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) :1197-1198
[4]  
BAUMEL H, 1987, CANC DIGESTIFS, P317
[5]   Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults [J].
Bernard, L ;
Ferrière, F ;
Casassus, P ;
Malas, F ;
Lévêque, S ;
Guillevin, L ;
Lortholary, O .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :914-915
[6]  
Blay JY, 1997, INT J CANCER, V72, P424, DOI 10.1002/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO
[7]  
2-R
[8]   Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation [J].
Blijlevens, NMA ;
Donnelly, JP ;
Meis, JFGM ;
De Keizer, MH ;
De Pauw, BE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) :889-892
[9]  
BOGGS DR, 1960, CANCER-AM CANCER SOC, V13, P1240, DOI 10.1002/1097-0142(196011/12)13:6<1240::AID-CNCR2820130613>3.0.CO
[10]  
2-9